T. Rowe Price Associates’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $141M | Buy |
|
|||||
|
2025
Q2 | $84.8M | Buy |
|
|||||
|
2025
Q1 | $63.5M | Buy |
|
|||||
|
2024
Q4 | $38.4M | Buy |
|
|||||
|
2024
Q3 | $28.8M | Buy |
|
|||||
|
2024
Q2 | $21.6M | Buy |
|
|||||
|
2024
Q1 | $20.9M | Sell |
|
|||||
|
2023
Q4 | $26.3M | Buy |
|
|||||
|
2023
Q3 | $4.82M | Sell |
|
|||||
|
2023
Q2 | $3.68M | Buy |
|
|||||
|
2023
Q1 | $3.06M | Buy |
|
|||||
|
2022
Q4 | $414K | Sell |
|
|||||
|
2022
Q3 | $400K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $149K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $218K | Hold |
|
|||||
|
2021
Q2 | $327K | Buy |
|
|||||
|
2021
Q1 | $329K | Buy |
|
|||||
|
2020
Q4 | $454K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $19.2M | Sell |
|
|||||
|
2019
Q3 | $18.5M | Sell |
|
|||||
|
2019
Q2 | $23.6M | Buy |
|
|||||
|
2019
Q1 | $27.6M | Buy |
|
|||||
|
2018
Q4 | $21.3M | Buy |
|
|||||
|
2018
Q3 | $23M | Buy |
|
|||||
|
2018
Q2 | $17.3M | Buy |
|
|||||
|
2018
Q1 | $8.42M | Buy |
|
|||||
|
2017
Q4 | $8.84M | Buy |
|